Evidence-Based Practice Module 4

Activity Preview

This activity is intended for BCACPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This series will feature succinct commentaries about practice-changing evidence through a series of podcasts, articles. online panel discussions, and polls. This module consists of 4 activities and offers up to 2 hours of continuing pharmacy education and/or recertification credit. These activities are produced in conjunction with iForumRx and are part of the APhA professional development program for BCACP recertification approved by BPS.

Additional Modules can be found here:

Module 1
Module 2
Module 3
Module 4
Module 5

Learning Objectives

At the completion of this activity, the participant will be able to:

Addressing the Concerns and Needs of Transgender Persons

LO1: Identify specific health and social issues affecting the TGNC population

LO2: Utilize appropriate resources for increasing knowledge on TGNC care

LO3: Identify the recommended survey methods for minority and marginalized patient populations

LO4: Apply techniques to demonstrate cultural sensitivity to TGNC individuals

The Importance of a Healthy Mind in Patients with an Unhealthy Heart: The Effect of Escitalopram vs Placebo for Treatment of Depression in Patients with Acute Coronary Syndrome

LO1: Choose the potential mechanism(s) contributing to the relationship between depression and acute coronary syndrome (ACS).

LO2: Identify which antidepressant medications may worsen cardiovascular outcomes from those that may benefit cardiovascular outcomes in patients who are post-ACS.

LO3: Given a patient scenario, recommend antidepressant therapy that is considered safe from a cardiovascular perspective in patients who are post-ACS that may benefit from treatment of depression.

Medication Synchronization: Friend or Foe?

LO1: Describe the medication synchronization (med sync or similar) program process for managing patient prescriptions for new and refilled medications.

LO2: Evaluate the med sync (or similar) programs in the ambulatory care arena as they apply to opportunities for patient intervention.

LO3: Discuss the role of med sync programs in pharmacy STAR ratings and Medicare performance markers.

Using CRP in COPD to Guide Treatment Decisions during Exacerbations

LO1: Recommend a treatment plan for a patient with a COPD exacerbation.

LO2: Identify when point-of-care C-reactive protein testing may be used to decide whether to prescribe antibiotics for COPD exacerbations based on the PACE study.

LO3: Utilize point-of-care C-reactive protein testing results to decide whether to prescribe antibiotics for COPD exacerbations based on the PACE study.

LO4: Recognize regulations regarding point-of-care testing.

Activity type: Application-based

Target Audience: Pharmacists 

Learning level: 2

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 0.2 contact hours of CPE credit (0.2 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-280-H04-P.

To obtain credit for Evidence-Based Practice Module 4, complete the learning activities, assessment with a grade of 71% or better, and evaluation questions. Then, you will be able to claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

Initial release date: December 5, 2019
Expiration date: December 5, 2022 

Development

Evidence-Based Practice Module 4 is an online educational activity for pharmacists developed by the American Pharmacists Association.

Disclosures

APhA’s editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association. 

Fee

Member: $40
Non-member: $70

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.